Cefoxitin
Approved
Approval ID
2a9d1e7b-96ee-4e6c-a1e8-47b76b924422
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 10, 2023
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefoxitin Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-341
Application NumberANDA065414
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefoxitin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 6, 2022
FDA Product Classification
INGREDIENTS (1)
CEFOXITIN SODIUMActive
Quantity: 1 g in 1 1
Code: Q68050H03T
Classification: ACTIM
Cefoxitin Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-342
Application NumberANDA065414
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefoxitin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 6, 2022
FDA Product Classification
INGREDIENTS (1)
CEFOXITIN SODIUMActive
Quantity: 2 g in 1 1
Code: Q68050H03T
Classification: ACTIM